Publications by authors named "Igor Samoylenko"

Claim this Profile
C
Corrigendum to "Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial" [Eur J Cancer. 227 (2025) 115674].
Lev Demidov, Igor Samoylenko, Galina Kharkevich, Kristina Orlova, Vladimir Moiseenko

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial.
Lev Demidov, Igor Samoylenko, Galina Kharkevich, Kristina Orlova, Vladimir Moiseenko

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, Zeynep Eroglu, Shahneen Sandhu, Igor Samoylenko

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.
Thomas Eigentler, Ioannis Thomas, Igor Samoylenko, Michael Erdmann, Lucie Heinzerling

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers.
Sofia V Krasik, Ekaterina A Bryushkova, George V Sharonov, Daria S Myalik, Elizaveta V Shurganova, Igor V Samoylenko

Elife· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study.
Igor V Samoylenko, Yulia M Kolontareva, Ekaterina V Kogay, Natalia V Zhukova, Igor A Utyashev

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pinpointing the tumor-specific T cells via TCR clusters.
Mikhail M Goncharov, Ekaterina A Bryushkova, Nikita I Sharaev, Valeria D Skatova, Anastasiya M Baryshnikova, Igor V Samoylenko

Elife· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Kristina V Orlova, Evgeniy V Ledin, Natalia V Zhukova, Rashida V Orlova, Elena V Karabina, Igor V Samoylenko

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma.
Josep Malvehy, Igor Samoylenko, Dirk Schadendorf, Ralf Gutzmer, Jean-Jacques Grob

J Immunother Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for Melanoma and Other Skin Cancer Shows a Higher Early Melanoma Incidence: Social Educational Program "Life Fear-Free".
Lev Demidov, Igor Samoylenko, Nina Vand, Igor Utyashev, Irina Shubina

Dermatopathology (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
Mikhail Kiselevskiy, Irina Shubina, Irina Chikileva, Suria Sitdikova, Igor Samoylenko

Pharmaceuticals (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring Intratumoral Heterogeneity of Immune Repertoires.
Diana Vladimirovna Yuzhakova, Lilia N Volchkova, Mikhail Valerievich Pogorelyy, Ekaterina O Serebrovskaya, Irina A Shagina, Igor V Samoylenko

Front Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis